Walter A. Korfmacher
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, Mass Spectrometry Techniques and Applications, Pesticide Residue Analysis and Safety, Metabolomics and Mass Spectrometry Studies, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Direct analysis of drug candidates in tissue by matrix‐assisted laser desorption/ionization mass spectrometry(2003)360 cited
- → Investigation of matrix effects in bioanalytical high‐performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery(2002)343 cited
- Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.(1998)
- → Discovery of (1 R ,5 S )- N -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( S )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( S )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection(2006)278 cited
- → Foundation review: Principles and applications of LC-MS in new drug discovery(2005)262 cited
- → It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS(2011)